Global Blood Therapeutics, Inc. (NASDAQ:GBT)

WEB NEWS

All | Comments & Business Outlook | Deal Flow

Tuesday, June 21, 2016

Deal Flow

PRICE $18.75 A SHARE

 

 

 

                         
    Price to
Public		     Underwriting
Discounts and
Commissions (1)		     Proceeds, before
expenses, to
Global Blood
Therapeutics, Inc.		  

Per Share

   $ 18.75     $ 1.1250     $ 17.6250  

Total

   $ 120,000,000     $ 7,200,000     $ 112,800,000  
Permalink

Friday, June 10, 2016

Deal Flow

CALCULATION OF REGISTRATION FEE

 

         

 

Title of Each Class of

Securities to be Registered

  

Proposed
Maximum
Aggregate

Offering Price (1)

  

Amount of

Registration Fee (2)

Common Stock, par value $0.001 per share

   $115,000,000   $11,580.50

 

 

Permalink

Thursday, May 12, 2016

Comments & Business Outlook
GLOBAL BLOOD THERAPEUTICS, INC.
Condensed Statements of Operations and Comprehensive Loss
(Unaudited)
(In thousands, except share and per share amounts)
 
 
               
 
Three Months Ended 
 March 31,
 
2016
 
2015
Operating expenses:
 
 
 
Research and development
$
12,415

 
$
6,069

General and administrative
4,302

 
1,298

Related party expenses
—

 
53

Total operating expenses
16,717

 
7,420

Loss from operations
(16,717
)
 
(7,420
)
Interest income
117

 
3

Net loss and comprehensive loss
$
(16,600
)
 
$
(7,417
)
Net loss attributable to common stockholders
$
(16,600
)
 
$
(8,657
)
Net loss per share attributable to common stockholders, basic and diluted
$
(0.56
)
 
$
(4.22
)
Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic and diluted
29,441,404

 
2,052,874

Permalink


Market Data powered by QuoteMedia. Terms of Use